Yankees Score with ...
Health Care: Drugs
Actavis Inc (ACT: NYSE)
$127.23 -0.85 | -0.66%
05/24/13 - 04:00 PM ET
Insider Trading
| Historical Data | Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | 4 Mo. Ago | 5 Mo. Ago | 6 Mo. Ago |
|---|---|---|---|---|---|---|---|
| Net Insider Transaction | 49,447 | 48,636 | 47,268 | -2,179 | -6,368 | 25,363 | 25,363 |
| Shares Bought | 49,447 | 49,447 | 87,697 | 89,950 | 109,950 | 215,575 | 163,875 |
| Shares Sold | 0 | 811 | 40,429 | 92,129 | 116,318 | 190,212 | 138,512 |
Institutional Trading
| Historical Data | Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | 4 Mo. Ago | 5 Mo. Ago | 6 Mo. Ago |
|---|---|---|---|---|---|---|---|
| Total Shares Held | 104.34M | 106.49M | 106.63M | 106.71M | 113.65M | 114.36M | 113.27M |
| Shares Bought | 12.76M | 9.99M | 9.83M | 10.37M | 14.94M | 15.96M | 15.91M |
| Shares Sold | 17.95M | 14.21M | 14.46M | 16.45M | 15.77M | 15.12M | 14.82M |
Portfolios with ACT
- Portfolio NameUser Type
- ContributorHigh Volume Technicals for ...
- ContributorHigh Volume Technicals for ...
Latest ACT Headlines from TheStreet
- Actavis Reaches New 52-Week High (ACT) 04.19.13 | 04:04 pm
- Actavis Inc (ACT): Drugs' Featured Winner Of The Day 04.05.13 | 05:04 pm
- Actavis Inc Stock Upgraded (ACT) 04.03.13 | 05:04 am
- Stocks to Watch: Nasdaq OMX, Goldman, Ford, GM 04.02.13 | 05:04 am
- Actavis Stock Hits New 52-Week High (ACT) 04.01.13 | 09:04 am
- 5 Huge Stocks to Trade for Gains This Week 03.14.13 | 10:03 am
- Actavis Reaches New 52-Week High (ACT) 03.13.13 | 01:03 pm
- Actavis Inc (ACT): Today's Featured Health Care Winner 02.26.13 | 05:02 pm
- 5 Big Stock Trades Signaling 'Buy' 02.14.13 | 11:02 am
- Cramer's 'Mad Money' Recap: Coaling a Bottom 10.07.05 | 07:10 pm
Press Releases for ACT
- Actavis To Acquire Warner Chilcott To Create Premier $11 Billion Revenue Global Specialty Pharmaceutical Company - PR Newswire 05.20.13 | 07:05 am
- Announcement Under Irish Takeover Rules Relevant Securities In Issue - PR Newswire 05.14.13 | 01:05 am
- Actavis Acquires Worldwide Rights For Valeant's Metronidazole 1.3% Vaginal Gel - PR Newswire 05.01.13 | 08:05 am
- Actavis Acquires Worldwide Rights For Valeant's Metronidazole 1.3% Vaginal Gel - PR Newswire 05.01.13 | 08:05 am
- Actavis Reaches Agreement With Shire To Launch A Generic Version Of Intuniv® In December 2014 - PR Newswire 04.25.13 | 09:04 am
- Actavis Reaches Agreements With Valeant To Launch Generic Versions Of Ziana® And Zyclara® - PR Newswire 04.10.13 | 08:04 am
- Actavis Reaches Agreements With Valeant To Launch Generic Versions Of Ziana® And Zyclara® - PR Newswire 04.10.13 | 08:04 am
- Actavis And Valeant Announce Actavis As Exclusive Authorized Generic Marketer Of Zovirax® Ointment; Co-Promotion Agreements On Zovirax® Cream And Cordran® Tape - PR Newswire 04.05.13 | 08:04 am
- Actavis And Valeant Announce Actavis As Exclusive Authorized Generic Marketer Of Zovirax® Ointment; Co-Promotion Agreements On Zovirax® Cream And Cordran® Tape - PR Newswire 04.05.13 | 08:04 am
- Actavis Confirms Court Issues TRO Related To Generic Pulmicort RESPULES® Distribution - PR Newswire 04.03.13 | 06:04 am
Partner Headlines for ACT
- AstraZeneca loses US drug patent judgment - Financial Times 04.02.13 | 10:04 am
- Aetna Offloads Business and 4 Stocks At 52-Week Highs - Wall St. Cheat Sheet 04.02.13 | 09:04 am
- 4 Healthcare Stock Stories for Monday Investment Wellness - Wall St. Cheat Sheet 04.01.13 | 02:04 am
- 4 Healthcare Stock Stories for Monday Investment Wellness - Wall St. Cheat Sheet 04.01.13 | 02:04 am
- 'Pay For Delay' Case Could Change Generic Drug Rules - Investor's Business Daily 03.26.13 | 04:03 pm
